Milae Bioresources Co. Ltd (218150) — Capital Reinvestment Ratio
Milae Bioresources Co. Ltd (218150) has a Capital Reinvestment Ratio of 0.15x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩738.87 Million) in capital expenditures (₩114.42 Million). See Milae Bioresources Co. Ltd (218150) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Milae Bioresources Co. Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Milae Bioresources Co. Ltd's Capital Reinvestment Ratio across 7 annual periods. Check Milae Bioresources Co. Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Milae Bioresources Co. Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Milae Bioresources Co. Ltd from 2017 to 2025. For live market cap and broader valuation context, see 218150 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | ₩4.40 Billion | ₩454.35 Million | ▼ -46.9% |
| 2023 | 0.19x | ₩3.23 Billion | ₩628.02 Million | ▼ -52.5% |
| 2022 | 0.41x | ₩1.19 Billion | ₩488.08 Million | ▲ +123.6% |
| 2021 | 0.18x | ₩2.98 Billion | ₩546.14 Million | ▼ -29.3% |
| 2020 | 0.26x | ₩848.31 Million | ₩219.74 Million | ▲ +105.1% |
| 2019 | 0.13x | ₩3.56 Billion | ₩450.05 Million | ▼ -79.9% |
| 2017 | 0.63x | ₩4.18 Billion | ₩2.62 Billion | — |